Last $0.50 HKD
Change Today -0.02 / -3.85%
Volume 6.3M
401 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 3:01 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

wanjia group holdings ltd (401) Snapshot

Open
$0.52
Previous Close
$0.52
Day High
$0.52
Day Low
$0.49
52 Week High
03/10/14 - $0.99
52 Week Low
08/18/14 - $0.49
Market Cap
324.2M
Average Volume 10 Days
3.0M
EPS TTM
$0.08
Shares Outstanding
648.4M
EX-Date
--
P/E TM
6.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for WANJIA GROUP HOLDINGS LTD (401)

Related News

No related news articles were found.

wanjia group holdings ltd (401) Related Businessweek News

No Related Businessweek News Found

wanjia group holdings ltd (401) Details

Wanjia Group Holdings Limited operates in the wholesale and distribution of pharmaceutical and healthcare products in the Fujian Province in the People’s Republic of China through its subsidiaries. It trades prescription medicines and over-the-counter medicines, including branded and generic Western and Chinese medicines, as well as healthcare products, medical devices, and other products to public hospitals and healthcare institutions, as well as companies operating pharmaceutical retail chain stores, independent pharmacies, out-patient departments of community hospitals, healthcare service stations, and clinics; and to distributor customers. The company also offers retail of pharmaceutical products through retail pharmacies under the ‘Huihao Sihai’ brand name. As of September 20, 2013, it had 100 retail pharmacies in Fujian Province. The company was founded in 2004 and is headquartered in Fuzhou, China. Wanjia Group Holdings Limited operates as a subsidiary of Greatly Wealth Global Group Limited.

1,336 Employees
Last Reported Date: 11/14/14
Founded in 2004

wanjia group holdings ltd (401) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

wanjia group holdings ltd (401) Key Developments

Wanjia Group Holdings Limited Announces Resignation of Weng Jiaxing as Executive Director, Effective on November 21, 2014

Wanjia Group Holdings Limited announced that Weng Jiaxing, Executive Director has resigned. The effective date is November 21, 2014.

Wanjia Group Holdings Limited expected to report First-Half, 2015 results on November 28, 2014. This event was calculated by Capital IQ (Created on November 22, 2014).

Wanjia Group Holdings Limited expected to report First-Half, 2015 results on November 28, 2014. This event was calculated by Capital IQ (Created on November 22, 2014).

Wanjia Group Holdings Limited Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Wanjia Group Holdings Limited reported unaudited consolidated earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company has posted turnover of HKD 443,208,000 against HKD 505,792,000 a year ago. Profit from operations was HKD 874,000 against HKD 14,383,000 a year ago. Loss before taxation was HKD 1,279,000 against profit of HKD 13,066,000 a year ago. Loss for the period attributable to owners of the company was HKD 3,264,000 or 0.50 cents basic and diluted per share against profit of HKD 6,564,000 or 1.01 cents basic and diluted per share a year ago. For the six months, the company has posted turnover of HKD 841,754,000 against HKD 1,069,370,000 a year ago. Loss from operations was HKD 768,736,000 against profit of HKD 35,739,000 a year ago. Loss before taxation was HKD 772,763,000 against profit of HKD 33,338,000 a year ago. Loss for the period attributable to owners of the company was HKD 778,184,000 or 120 cents basic and diluted per share against profit of HKD 20,384,000 or 3.14 cents basic and diluted per share a year ago. Net cash generated from operating activities was HKD 45,920,000 against HKD 35,393,000 a year ago. The decrease in turnover was mainly attributable to decrease in revenue generated from the pharmaceutical wholesales segment as a result of the promulgation and implementation of new Good Supply Practice (New GSP) in Fujian, the People's Republic of China in April 2014 which imposes stringent regulations on pharmaceutical distributor operation. The loss from operation for the current period was mainly contributed to the impairment loss on goodwill of approximately HKD 785.483 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
401:HK $0.50 HKD -0.02

401 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Nepstar Chain Drugstore Ltd $1.65 USD -0.0699
Huadong Medicine Co Ltd CNY52.22 CNY +0.27
Jointown Pharmaceutical Group Co Ltd CNY17.44 CNY +0.60
Nanjing Pharmaceutical Co Ltd CNY8.15 CNY -0.04
View Industry Companies
 

Industry Analysis

401

Industry Average

Valuation 401 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 1.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WANJIA GROUP HOLDINGS LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.